1. Analytical Methods for the New Candidate Priority Substances
CMEP Meeting, JRC, Geel, Belgium, November 2011
Analytical Methods for the New Candidate
Priority Substances
Comments from EU Member States
CMEP Meeting, JRC, Geel, Belgium, November 2011
NOTES
1. PLACE, DATE AND EVENT NAME
1.1. Access the slide-set place, date and event name text box beneath the JRC logo from the Slide Master.
1.2. Do not change the size nor the position of that text box.
1.3. Replace the mock-up texts for the place (“Place”), the date (“dd Month YYYY”) and the event name (“Event Name”) with your own texts.
1.4. Set it in MetaPlus Book Roman, if you own the typeface. Otherwise, keep the original typeface – Arial.
1.5. Keep the original flush-left justification.
1.6. Keep the original font colour (white).
1.7. Keep the original font body size (7 pt) and the text on one single line.
2. SLIDE NUMBER
2.1. The slide number on the banner’s lower right-hand side is automatically generated.
3. SLIDES
3.1. Duplicate the first slide as needed.
3.2. Do not change the size nor the position of the slide’s text box.
3.3. Try not to place more text on each slide than will fit in the given text box.
3.4. Replace the mock-up heading text (“Joint Research Centre (JRC)”) with your own text heading.
3.5. Set it in Eurostile Bold Extended Two or in Helvetica Rounded Bold Condensed, if you own one of these typefaces. Otherwise, keep the original typeface – Arial.
3.6. Keep the original flush-left justification.
3.7. Keep the original font colour (100c 80m 0y 0k).
3.8. Keep the original font body size (28 pt) and the heading on one single line whenever possible. Reduce the font body size if needed.
3.9. Replace the mock-up text (“The European Commission’s Research-Based Policy Support Organisation)”) with your own text.
3.10. Set it in MetaPlus Book Roman, if you own the typeface. Otherwise, keep the original typeface – Arial.
3.11. Keep the original flush-left justification.
3.12. Keep the original font colour (100c 80m 0y 0k). Use black if you need a second colour.
3.13. Keep the original font body size (22 pt) or reduce it if unavoidable.
3.14. Replace the EU-27 map mock-up illustration with your own illustration(s).
3.13. Try to keep your illustration(s) right- and top- or bottom-aligned with the main text box whenever possible.
Robert Loos (JRC-IES),

2. Pesticides Aclonifen Bifenox (Herbicide) Cybutryne = Irgarol
CMEP Meeting, JRC, Geel, Belgium, November 2011
Aclonifen
(Herbicide)
Bifenox (Herbicide)
Cybutryne = Irgarol
(Triazine herbicide = algicide)
Cypermethrin
(Pyrethroide Insecticide)
Dicofol
(Miticide)
Heptachlor (epoxide)
(Insecticide)
Dichlorvos
(Phospho-ester Insecticide)
Quinoxyfen
(Fungicide)
Terbutryn
(Triazine herbicide = algicide)

3. POPs Hexabromocyclododecane (HBCDD) PCBs PFOS
CMEP Meeting, JRC, Geel, Belgium, November 2011
Hexabromocyclododecane (HBCDD)
Brominated flame retardant
PCBs
PFOS
Fluorosurfactant
2,3,7,8-Tetrachlorodibenzodioxin

4. Pharmaceutical Compounds
CMEP Meeting, JRC, Geel, Belgium, November 2011
Diclofenac, NSAID
Ibuprofen, NSAID
17β-estradiol
Estradiol is the predominant sex hormone present in females
17a-ethinyl-estradiol
Contraceptive baby pill

5. AA-EQS for the Candidate PS
CMEP Meeting, JRC, Geel, Belgium, November 2011
Substance AA-EQS Substance AA-EQS
Aclonifen mg/L (salt: 0.012) 17-alpha-ethinylestradiol 35 pg/L (salt: 3.5)
Bifenox ng/L (salt: 1.25 ng/L) 17-beta-estradiol 0.4 ng/L (s: 40 pg/L)
Cyanides (free) 0.1 mg/L (salt: 0.01) Heptachlor / heptachlor epoxide 0.21 pg/L (s: 0.01)
Cybutryne (Irgarol) 2.5 ng/L HBCDD (Hexabromocyclododecane)1.6 ng/L (s: 0.8)
Cypermethrin 82 pg/L (salt: 8.2) Ibuprofen 10 ng/L
Dichlorvos 0.6 ng/L (salt: 60 pg/L) PFOS ng/L (s:0.13)
Diclofenac 0.1 mg/L (salt: 0.01) Quinoxyfen mg/L (s: 0.015)
Dicofol ng/L (salt: 15 pg/L) Terbutryn 65 ng/L (s: 6.5)
Dioxin
Dioxin-like PCBs
PCBs (non-dioxin like)

6. Standard Methods for new PS
CMEP Meeting, JRC, Geel, Belgium, November 2011
Substance Standard Method Principle Matrix MQL
Aclonifen
Bifenox
Cyanides (free) ISO 14403:2009 Flow injection
Cybutryne = Irgarol
Cypermethrin EPA 1699 (2007) HRGC/HRMS Water, Solids, Tissue 66 pg/L; 2.4 ng/kg
Dichlorvos EPA 622 GC/FPD Water 0.1 mg/L
Diclofenac
Dicofol
Dioxin EPA 1613; ISO HRGC/HRMS Water, Soil, Sediment, Sludge pg/L; 1-5 ng/kg
17-alpha-ethinylestradiol EPA 1698 (2007) HRGC/HRMS Water, Soil, Sediment 0.1 ng/L; 10 ng/kg
17-beta-estradiol EPA 1698 (2007) HRGC/HRMS Water, Soil, Sediment 0.1 ng/L; 10 ng/kg
Heptachlor / heptachlor epoxide EPA 1699 (2007); HRGC/HRMS Water, Solids, Tissue 7 pg/L; 0.3 ng/kg
HBCDD (Hexabromocyclododecane)
PFOS ISO (2009) LC-MS-MS Water mg/L
Quinoxyfen
Terbutryn EPA 619 GC/N detector Water mg/L
Ibuprofen EPA 1694 (2007) LC-MS-MS Water, Soil, Sediment 6 ng/L; 11 ng/g
Dioxin-like PCBs ISO (2007) HRGC/HRMS Waters and Wastewaters
PCBs (non-dioxin like) EPA 525-1, 608 GC/MS (ECD) Water 0.1 mg/L

7. Comments from EU Member States
CMEP Meeting, JRC, Geel, Belgium, November 2011
Comments received from:
Bulgaria
Denmark
France
Italy
Ireland
Lithuania
Sweden
UK (EA and SEPA)
Northern Ireland
(integrated in the Table)
General comments from:
Austria
Belgium
Poland

8. Comment from Austria
CMEP Meeting, JRC, Geel, Belgium, November 2011
Austria: A. Rauchbüchel, K. Deutsch, 21 March 2011
“The lack of analytical methods for quite a number of parameters in the table and the insufficient sensitivity for some of the available methods confirm our concerns regarding the technical feasibility of compliance checking for the proposed EQS of existing and candidate priority substances.
Furthermore the table displays the situation too optimistic from our point of view insofar as it considers US EPA methods in many cases. These methods usually require highly sophisticated laboratory equipment which presumably is not available in all Austrian (routine) water laboratories.
Additionally the table reflects the urgent need to push forward the development of CEN and /or ISO methods for the listed substances.”